









Markets
/
Stocks
/
nasdaq-artv
/

Artiva Biotherapeutics Inc

ARTV

4.490USD

-0.250-5.27%

Market hours （ET）Quotes delayed by 15 min

110.21MMarket Cap

LossP/E TTM



Artiva Biotherapeutics Inc

4.490

-0.250-5.27%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Artiva Biotherapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q2

FY2023Q1

FY2022Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-65.37%-19.20M

-67.94%-22.98M

-31.52%-19.84M

---14.65M

---11.61M

-16.33%-13.69M

-5.92%-15.09M

---11.76M

-47.38%-14.24M

---9.66M

Net income from continuing operations

-23.21%-21.53M

-19.12%-21.25M

-45.46%-20.31M

---16.09M

---17.47M

-58.13%-17.84M

16.47%-13.96M

---11.28M

-37.88%-16.72M

---12.12M

Operating gains losses

5.58%662.00K

6.30%641.00K

6.98%628.00K

--614.00K

--627.00K

12.08%603.00K

1.56%587.00K

--538.00K

246.11%578.00K

--167.00K

Other non-cash items

45.83%-357.00K

-86.45%-509.00K

-96.47%-723.00K

---1.04M

---659.00K

-1850.00%-273.00K

---368.00K

---14.00K

--0.00

----

Change in working capital

-87.01%391.00K

-48614.29%-3.41M

50.70%-1.49M

---311.00K

--3.01M

99.80%-7.00K

-4812.50%-3.02M

---3.46M

-93.11%64.00K

--929.00K

-Change in receivables

-106.45%-49.00K

-22.14%204.00K

-351.43%-88.00K

--555.00K

--760.00K

116.91%262.00K

104.26%35.00K

---1.55M

-9.89%-822.00K

---748.00K

-Change in prepaid expenses

112.92%194.00K

-1067.57%-2.86M

19.87%-750.00K

--176.00K

---1.50M

-77.39%296.00K

-291.63%-936.00K

--1.31M

72.14%-239.00K

---858.00K

-Change in other current assets

-1287.50%-380.00K

-180.65%-25.00K

719.35%254.00K

--31.00K

--32.00K

3.33%31.00K

-6.06%31.00K

--30.00K

--33.00K

----

-Change in other current liabilities

----

--0.00

100.00%0.00

-100.00%0.00

---1.55M

110.67%72.00K

---675.00K

Cash from non-recurring investing activities

Cash from operating activities

-65.37%-19.20M

-67.94%-22.98M

-31.52%-19.84M

---14.65M

---11.61M

-16.33%-13.69M

-5.92%-15.09M

---11.76M

-47.38%-14.24M

---9.66M

Investing cash flow

Net cash from continuing investing activities

525.00%600.00K

127.37%1.05M

2738.89%511.00K

--64.00K

--96.00K

-20.14%464.00K

-99.03%18.00K

--581.00K

209.30%1.86M

--602.00K

Capital expenditures

525.00%600.00K

127.37%1.05M

2738.89%511.00K

--64.00K

--96.00K

-20.14%464.00K

-99.03%18.00K

--581.00K

209.30%1.86M

--602.00K

Net cash flow from disposal of fixed assets

525.00%600.00K

127.37%1.05M

2738.89%511.00K

--64.00K

--96.00K

-20.14%464.00K

-99.03%18.00K

--581.00K

209.30%1.86M

--602.00K

Net cash flow from investment products

112.93%16.88M

1123.22%22.18M

6.96%10.48M

---902.00K

---130.53M

108.90%1.81M

--9.80M

---20.37M

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

112.46%16.28M

1465.75%21.12M

1.93%9.97M

---966.00K

---130.63M

106.44%1.35M

625.35%9.78M

---20.95M

-209.30%-1.86M

---602.00K

Financing cash flow

Cash flow from continuous financing activities

-100.02%-37.00K

95.54%-72.00K

--239.00K

---30.00K

--163.87M

-16260.00%-1.62M

----

--10.00K

96.07%-12.00K

---305.00K

Net cash flow from debt Issuance/repayment

15.79%-32.00K

57.69%-33.00K

---33.00K

---38.00K

---78.00K

----

Net cash flow from common stock issuance/repurchase

-99.94%99.00K

--0.00

--134.00K

--0.00

--166.51M

----

---12.00K

----

Net cash flow from preferred stock issuance/repurchase

----

--0.00

Proceeds from stock option exercised by employees

-100.00%0.00

--138.00K

--23.00K

--6.00K

0.00%22.00K

----

--22.00K

----

--199.00K

Net cash flow from other financing activities

96.00%-104.00K

97.50%-39.00K

----

---20.00K

---2.60M

---1.56M

----

---504.00K

Net cash from non-recurrent financing activities

Net cash from financing activities

-100.02%-37.00K

95.54%-72.00K

--239.00K

---30.00K

--163.87M

-16260.00%-1.62M

----

--10.00K

96.07%-12.00K

---305.00K

Net cash flow

Beginning cash balance

-16.16%28.93M

-36.31%30.86M

-24.68%40.49M

--56.14M

--34.51M

-44.08%48.46M

-47.69%53.76M

--86.66M

-36.23%102.78M

--161.17M

Current period cash flow changes

-113.68%-2.96M

86.15%-1.93M

-81.58%-9.63M

---15.65M

--21.63M

57.34%-13.95M

67.09%-5.30M

---32.71M

-52.46%-16.12M

---10.57M

Ending cash balance

-53.74%25.97M

-16.16%28.93M

-36.31%30.86M

--40.49M

--56.14M

-36.04%34.51M

-44.08%48.46M

--53.95M

-42.46%86.66M

--150.60M

Free cash flow

-69.14%-19.80M

-69.89%-24.04M

-34.75%-20.35M

---14.71M

---11.71M

-14.61%-14.15M

6.22%-15.10M

---12.35M

-56.88%-16.11M

---10.27M

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

